ASCO 2023: Breast cancer research highlights
ASCO 2023: Breast cancer research highlights
Adding ribociclib to endocrine therapy shows an improvement in invasive disease-free survival in HR+/HER2 BC patients
AI-derived digital pathology-based biomarker predicts benefit of long-term ADT with RT in localised high-risk prostate cancer
Optimising cervical cancer care in Nigeria
Choosing cancer medicines wisely in Africa
Olaparib plus ceralasertib might benefit paediatric cancer patients with DNA repair-deficient tumours
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
War in Ukraine: Support from Lymphoma Coalition for Ukrainian haematological cancer patients
Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death
Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non-epithelioid pleural mesothelioma
Breast and emerging indications for IORT
The advantages of IORT for early breast cancer treatment